《TRIPS协定》框架下药品专利强制许可规则的比较研究  

A Comparative Study on Compulsory Licensing Rules for Pharmaceutical Patents under the Framework of the TRIPS Agreement

作　　者：高翔宇 段妍羽 Gao Xiangyu;Duan Yanyu(Xi’an Institute of Electronic Engineering,Xi’an 710000;Xi’an Institute of Modern Control Technology,Xi’an 710000)

机构地区：[1]西安电子工程研究所,陕西西安710000 [2]西安现代控制技术研究所,陕西西安710000

出　　处：《中阿科技论坛（中英文）》2022年第6期206-210,共5页China-Arab States Science and Technology Forum

摘　　要：《TRIPS协定》是目前世界上实行的知识产权保护的国际标准,药品的研发技术、生产配方及工艺流程被赋予专利权保护后,药品价格因专利独占而变得高昂,而越来越多的发展中国家不得不实施《TRIPS协定》中的强制许可。本文通过对发达国家和地区、发展中国家对于强制许可规定的现状以及相关法律做比较,结合我国的实施情况,提出了在专利法中增添有关“公共健康的药品的专利强制许可”规定等5条具体建议,旨在有效解决我国实施强制许可中存在的相关问题。The TRIPS Agreement is the international standard for intellectual property protection currently implemented in the world.After the R&D technology,production formula and process flow of pharmaceutical products are granted patent protection,the price of pharmaceutical products has become high due to patent monopoly.Therefore,more and more developing countries have to resort to compulsory licenses in the TRIPS Agreement.By comparing the current situation of compulsory licensing provisions in developed countries,regions,and developing countries and related laws,specific recommendations are put forward such as adding provisions on“compulsory licensing of patents for public health medicines”to the Patent Law,aiming to effectively solve the relevant problems in the implementation of compulsory licensing provisions in China.

关 键 词：《TRIPS协定》 药品专利 公共健康 强制许可 

分 类 号：DF971[政治法律—国际法学]